Management Plan for Schedule 2 Myocardial Infarction
The management of a patient with Schedule 2 myocardial infarction requires immediate reperfusion therapy followed by comprehensive pharmacological treatment to reduce mortality and improve outcomes.
Initial Management
- Immediate assessment with 12-lead ECG to confirm ST-segment elevation or new left bundle-branch block 1
- Administer aspirin 160-325 mg orally immediately 2, 1
- Initiate reperfusion therapy as soon as possible - either primary PCI (preferred) or fibrinolytic therapy if PCI cannot be performed in a timely manner 2, 1
- Administer a potent P2Y12 inhibitor (prasugrel or ticagrelor, or clopidogrel if these are unavailable) before or at the time of PCI 2, 3
- Provide pain relief with appropriate analgesics (opioids) 2
- Place patient on continuous cardiac monitoring 2
Pharmacological Therapy
- Continue aspirin 75-100 mg daily indefinitely 2, 1
- Maintain dual antiplatelet therapy (DAPT) with aspirin plus a P2Y12 inhibitor for 12 months after PCI 2, 3
- Administer intravenous beta-blockers followed by oral therapy, provided there are no contraindications 2, 1
- Administer intravenous nitroglycerin for 24-48 hours, then transition to oral nitrates as needed 2
- Initiate ACE inhibitors within the first 24 hours in patients with evidence of heart failure, LV systolic dysfunction, diabetes, or anterior infarction 2, 1
- Start high-intensity statin therapy as early as possible 2
- Consider anticoagulation with heparin for patients who received fibrinolytic therapy 2
Monitoring and Management of Complications
- Monitor for arrhythmias with continuous ECG for at least 24 hours 2
- Perform echocardiography to assess LV and RV function, detect mechanical complications, and exclude LV thrombus 2
- For heart failure, administer diuretics (usually IV furosemide) and afterload-reducing agents 2
- For cardiogenic shock, consider intra-aortic balloon pump and emergency coronary angiography followed by PCI or CABG 2, 1
- For recurrent chest pain due to pericarditis, administer high-dose aspirin (650 mg every 4-6 hours) 2
- For recurrent ischemic chest pain, administer IV nitroglycerin, analgesics, and antithrombotic medications 2
Pre-Discharge Evaluation
- Perform standard exercise testing (submaximal at 4-7 days or symptom-limited at 10-14 days) 2, 1
- Assess functional capacity, evaluate efficacy of current medical regimen, and stratify risk for subsequent cardiac events 2
- Consider coronary angiography for patients with recurrent ischemia or high-risk features 2
Long-Term Management
- Continue aspirin, beta-blockers, and ACE inhibitors indefinitely 2, 1
- Maintain LDL cholesterol below 100 mg/dL (preferably below 70 mg/dL) with statin therapy 2
- Encourage smoking cessation with appropriate support and medications 2, 1
- Recommend participation in a cardiac rehabilitation program 2, 1
- Advise regular exercise (at least 20 minutes of brisk walking three times weekly) 2, 1
- Provide dietary guidance for weight management and reduction of saturated fat and cholesterol 2
Common Pitfalls and Caveats
- Avoid calcium channel blockers as they have not been shown to reduce mortality and may be harmful in certain patients 2
- Avoid intravenous beta-blockers in patients with hypotension, acute heart failure, AV block, or severe bradycardia 2
- Do not delay reperfusion therapy - benefit decreases significantly with time from symptom onset 1, 4
- Be cautious with antiplatelet therapy in patients who are CYP2C19 poor metabolizers, as clopidogrel may have reduced efficacy 3
- Avoid concomitant use of clopidogrel with omeprazole or esomeprazole as they significantly reduce antiplatelet activity 3